pubmed-article:8082082 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:8082082 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:8082082 | lifeskim:mentions | umls-concept:C0020792 | lld:lifeskim |
pubmed-article:8082082 | lifeskim:mentions | umls-concept:C0085295 | lld:lifeskim |
pubmed-article:8082082 | lifeskim:mentions | umls-concept:C0229671 | lld:lifeskim |
pubmed-article:8082082 | lifeskim:mentions | umls-concept:C1332225 | lld:lifeskim |
pubmed-article:8082082 | lifeskim:mentions | umls-concept:C0034819 | lld:lifeskim |
pubmed-article:8082082 | lifeskim:mentions | umls-concept:C1749467 | lld:lifeskim |
pubmed-article:8082082 | lifeskim:mentions | umls-concept:C1511790 | lld:lifeskim |
pubmed-article:8082082 | lifeskim:mentions | umls-concept:C0162643 | lld:lifeskim |
pubmed-article:8082082 | lifeskim:mentions | umls-concept:C1515021 | lld:lifeskim |
pubmed-article:8082082 | lifeskim:mentions | umls-concept:C0332167 | lld:lifeskim |
pubmed-article:8082082 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:8082082 | pubmed:dateCreated | 1994-10-13 | lld:pubmed |
pubmed-article:8082082 | pubmed:abstractText | This study explores the ability of the combined detection of soluble IL-2 receptor (sIL-2r) and interleukin-10 (IL-10) to predict treatment failure in patients with aggressive non-Hodgkin's lymphoma (NHL) and to evaluate the modifications in cytokine measurements induced by the therapeutic administration of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF). | lld:pubmed |
pubmed-article:8082082 | pubmed:language | eng | lld:pubmed |
pubmed-article:8082082 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8082082 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:8082082 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8082082 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8082082 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8082082 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:8082082 | pubmed:month | Sep | lld:pubmed |
pubmed-article:8082082 | pubmed:issn | 0008-543X | lld:pubmed |
pubmed-article:8082082 | pubmed:author | pubmed-author:PapaGG | lld:pubmed |
pubmed-article:8082082 | pubmed:author | pubmed-author:DammaccoFF | lld:pubmed |
pubmed-article:8082082 | pubmed:author | pubmed-author:TuraSS | lld:pubmed |
pubmed-article:8082082 | pubmed:author | pubmed-author:DamasioEE | lld:pubmed |
pubmed-article:8082082 | pubmed:author | pubmed-author:StarrDD | lld:pubmed |
pubmed-article:8082082 | pubmed:author | pubmed-author:DispensaEE | lld:pubmed |
pubmed-article:8082082 | pubmed:author | pubmed-author:LautaV MVM | lld:pubmed |
pubmed-article:8082082 | pubmed:author | pubmed-author:GalieniPP | lld:pubmed |
pubmed-article:8082082 | pubmed:author | pubmed-author:ZinzaniLL | lld:pubmed |
pubmed-article:8082082 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:8082082 | pubmed:day | 15 | lld:pubmed |
pubmed-article:8082082 | pubmed:volume | 74 | lld:pubmed |
pubmed-article:8082082 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:8082082 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:8082082 | pubmed:pagination | 1792-800 | lld:pubmed |
pubmed-article:8082082 | pubmed:dateRevised | 2010-3-24 | lld:pubmed |
pubmed-article:8082082 | pubmed:meshHeading | pubmed-meshheading:8082082-... | lld:pubmed |
pubmed-article:8082082 | pubmed:meshHeading | pubmed-meshheading:8082082-... | lld:pubmed |
pubmed-article:8082082 | pubmed:meshHeading | pubmed-meshheading:8082082-... | lld:pubmed |
pubmed-article:8082082 | pubmed:meshHeading | pubmed-meshheading:8082082-... | lld:pubmed |
pubmed-article:8082082 | pubmed:meshHeading | pubmed-meshheading:8082082-... | lld:pubmed |
pubmed-article:8082082 | pubmed:meshHeading | pubmed-meshheading:8082082-... | lld:pubmed |
pubmed-article:8082082 | pubmed:meshHeading | pubmed-meshheading:8082082-... | lld:pubmed |
pubmed-article:8082082 | pubmed:meshHeading | pubmed-meshheading:8082082-... | lld:pubmed |
pubmed-article:8082082 | pubmed:meshHeading | pubmed-meshheading:8082082-... | lld:pubmed |
pubmed-article:8082082 | pubmed:meshHeading | pubmed-meshheading:8082082-... | lld:pubmed |
pubmed-article:8082082 | pubmed:meshHeading | pubmed-meshheading:8082082-... | lld:pubmed |
pubmed-article:8082082 | pubmed:meshHeading | pubmed-meshheading:8082082-... | lld:pubmed |
pubmed-article:8082082 | pubmed:meshHeading | pubmed-meshheading:8082082-... | lld:pubmed |
pubmed-article:8082082 | pubmed:meshHeading | pubmed-meshheading:8082082-... | lld:pubmed |
pubmed-article:8082082 | pubmed:year | 1994 | lld:pubmed |
pubmed-article:8082082 | pubmed:articleTitle | Detection of soluble interleukin-2 receptor and interleukin-10 in the serum of patients with aggressive non-Hodgkin's lymphoma. Identification of a subset at high risk of treatment failure. | lld:pubmed |
pubmed-article:8082082 | pubmed:affiliation | Department of Hematology, University of Rome Tor Vergata, Italy. | lld:pubmed |
pubmed-article:8082082 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8082082 | lld:pubmed |